Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity

Veterinary Microbiology

Volumn 162, Issue 2-4, 2013, Pages 396-407

  Paillot, R ^a   Prowse, L ^a   Montesso, F ^a   Huang, C M ^b   Barnes, H ^b   Escala, J ^b  

^a ANIMAL HEALTH TRUST   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Cell mediated immunity; Equine influenza; IFNgamma; Protection; Vaccine

Indexed keywords

CLENBUTEROL; DUVAXYN IET PLUS VACCINE; GAMMA INTERFERON; INFLUENZA VACCINE; PHENYLBUTAZONE; PROCAINE PENICILLIN; SULFADOXINE PLUS TRIMETHOPRIM; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; EQUINE INFECTIOUS VIRUS; EQUINE INFLUENZA; HORSE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA VIRUS A; NONHUMAN; PERIPHERAL LYMPHOCYTE; PROTEIN SYNTHESIS; SYMPTOM; TREATMENT DURATION; UNITED STATES; VIRUS ISOLATION; VIRUS SHEDDING; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; HORSE DISEASES; HORSES; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; INTERFERON-GAMMA; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION; VACCINES, INACTIVATED; VIRUS SHEDDING;

EQUIDAE; EQUINE INFLUENZA VIRUS;

EID: 84872498953     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.10.019     Document Type: Article

References (33)

1. Barquero N., Daly J.M., Newton J.R. Risk factors for influenza infection in vaccinated racehorses: lessons from an outbreak in Newmarket, UK in 2003. Vaccine 2007, 25:7520-7529.
2. Bryant N.A., Paillot R., Rash A.S., Medcalf E., Montesso F., Ross J., Watson J., Jeggo M., Lewis N.S., Newton J.R., Elton D.M. Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak. Vet. Res. 2010, 41:19.
3. Bryant N.A., Rash A.S., Russell C.A., Ross J., Cooke A., Bowman S., Macrae S., Lewis N.S., Paillot R., Zanoni R., Meier H., Griffiths L.A., Daly J.M., Tiwari A., Chambers T.M., Newton J.R., Elton D.M. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet. Microbiol. 2009, 138:41-52.
4. Bryant N.A., Rash A.S., Woodward A.L., Medcalf E., Helwegen M., Wohlfender F., Cruz F., Herrmann C., Borchers K., Tiwari A., Chambers T.M., Newton J.R., Mumford J.A., Elton D.M. Isolation and characterisation of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009. Vet. Microbiol. 2010.
5. Daly J.M., Yates P.J., Newton J.R., Park A., Henley W., Wood J.L., Davis-Poynter N., Mumford J.A. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines. Vaccine 2004, 22:4101-4109.
6. Daly J.M., Yates R.J., Browse G., Swann Z., Newton J.R., Jessett D., Davis-Poynter N., Mumford J.A. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Vet. J. 2003, 35:458-462.
7. Edlund Toulemonde C., Daly J., Sindle T., Guigal P.M., Audonnet J.C., Minke J.M. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet. Rec. 2005, 156:367-371.
8. Elton D., Bryant N. Facing the threat of equine influenza. Equine Vet. J. 2011, 43:250-258.
9. Foord A.J., Selleck P., Colling A., Klippel J., Middleton D., Heine H.G. Real-time RT-PCR for detection of equine influenza and evaluation using samples from horses infected with A/equine/Sydney/2007 (H3N8). Vet. Microbiol. 2009, 137:1-9.
10. Garner M.G., Cowled B., East I.J., Moloney B.J., Kung N.Y. Evaluating the effectiveness of early vaccination in the control and eradication of equine influenza-a modelling approach. Prev. Vet. Med. 2011, 99:15-27.
11. Gildea S., Arkins S., Cullinane A. Management and environmental factors involved in equine influenza outbreaks in Ireland 2007-2010. Equine Vet. J. 2011, 43:608-617.
12. Gildea S., Arkins S., Walsh C., Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt Horses-a randomised blind study. Vaccine 2011, 29:3917-3922.
13. Gildea S., Arkins S., Walsh C., Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings-a randomised blind study. Vaccine 2011, 29:9214-9223.
14. Hannant D., Jessett D.M., O'Neill T., Livesay G.J., Mumford J.A. Cellular immune responses stimulated by inactivated virus vaccines and infection with equine influenza virus (H3N8). Equine Infectious Diseases. VII. Proceedings of Seventh International Conference on Equine Infectious Diseases 1994, 169-174. R & W Publications Ltd., Newmarket, UK. H. Nakajima, W. Plowright (Eds.).
15. Krashias G., Simon A.K., Wegmann F., Kok W.L., Ho L.P., Stevens D., Skehel J., Heeney J.L., Moghaddam A.E., Sattentau Q.J. Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer. Vaccine 2010, 28:2482-2489.
16. Landolt G., Townsend H.G., Lunn D.P. Equine influenza infection. Equine Infectious Diseases 2007, 124-134. Saunders Elseiver. D.C. Sellon, M.T. Long (Eds.).
17. Lehnard R.A., Adams A.A., Betancout A., Horohov D., Liburt N.R., Streltsova J.M., Franke W.C., McKeever K.H. Phenylbutazone blocks the cytokine response following a high-intensity incremental exercise challenge in horses. Comp. Exerc. Physiol. 2011, 7:103-108.
18. Lindblad E.B. Aluminium adjuvants-in retrospect and prospect. Vaccine 2004, 22:3658-3668.
19. Mumford J.A. Control of influenza from an international perspective. Equine Infectious Diseases VIII: Proceedings of the 8th International Conference on Equine Infectious Diseases 1998, 11-24. R & W Publications, Newmarket, UK. U.J.F.W. Wernery, J.A. Mumford, O.-R. Kaaden (Eds.).
20. Mumford J.A., Jessett D.M., Dunleavy U., Wood J.L.N., Hannant D., Sundquist B., Cook R.F. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 1994, 12:857-863.
21. Mumford J.A., Wood J. Establishing an acceptability threshold for equine influenza vaccines. Dev. Biol. Stand. 1992, 79:137-146.
22. OIE Equine influenza. OIE Terrestrial Manual 2008 2008, (Chapter 2.5.7)
23. OIE OIE expert surveillance panel on equine influenza vaccine composition. OIE Bull. 2010, 44-45.
24. OIE OIE expert surveillance panel on equine influenza vaccine composition. OIE Bull. 2011, 50-51.
25. Paillot R., Grimmett H., Elton D., Daly J.M. Protection, systemic IFN and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host. Vet. Res. 2008, 39:21.
26. Paillot R., Hannant D., Kydd J.H., Daly J.M. Vaccination against equine influenza: quid novi?. Vaccine 2006, 24:4047-4061.
27. Paillot R., Kydd J.H., Macrae S., Minke J.M., Hannant D., Daly J.M. New assays to measure equine influenza virus-specific Type 1 immunity in horses. Vaccine 2007, 25:7385-7398.
28. Paillot R., Kydd J.H., Sindle T., Hannant D., Edlund Toulemonde C., Audonnet J.C., Minke J.M., Daly J.M. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Vet. Immunol. Immunopathol. 2006, 112:225-233.
29. Paillot R., Prowse L. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse. Vet. Immunol. Immunopathol. 2012, 145:516-521.
30. Paillot R., Prowse L., Donald C., Medcalf E., Montesso F., Bryant N., Watson J., Jeggo M., Elton D., Newton R., Trail P., Barnes H. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding. Vet. Immunol. Immunopathol. 2010, 136:272-283.
31. Park A.W., Wood J.L., Newton J.R., Daly J., Mumford J.A., Grenfell B.T. Optimising vaccination strategies in equine influenza. Vaccine 2003, 21:2862-2870.
32. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
33. Wood, J., 1991. Equine Influenza: history and epidemiology and a description of a recent outbreak. MSc. University of London, London.